Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2007
12/19/2007CN101088505A Nanometer breviscapine polymer particle prepn and its prepn process
12/19/2007CN101088504A Application of theasaponin in preparing externally applied spermicidal contraceptive
12/19/2007CN101088503A Freeze dried nimodipine powder for injection and its prepn
12/19/2007CN101088502A Mixture solution containing conjugate of transferrin and quercetin and its use
12/19/2007CN101088501A Prepn process of germanium containing nutrient solution
12/19/2007CN101088500A Cold treating medicine for children
12/19/2007CN101088499A Dry asarol emulsion and its prepn and application
12/19/2007CN101088498A Application of bakuchiol compound
12/19/2007CN101088497A Composition containing lycopane and thioglycoside
12/19/2007CN101088493A Nanometer alprosadil particle and its prepn process
12/19/2007CN101088492A Stable supersaturated gemcitabine hydrochloride solution and its prepn process
12/19/2007CN101088491A Anticancer composition
12/19/2007CN100355770C Method of determining a chemotherapeutic regimen based on glutathione-S-transferase pi expression
12/19/2007CN100355768C Novel tyrosinase inhibitor and use thereof
12/19/2007CN100355758C Guanidine derivatives and use thereof as neuropeptide FF receptor antagonists
12/19/2007CN100355756C Therapeutic agent for schizophrenia
12/19/2007CN100355755C Diazabicyclic central nervous system active agents
12/19/2007CN100355753C Tropan derivatives useful in therapy, method for obtaining thereof and intermediate compounds
12/19/2007CN100355751C 2-substd. 4-heteroaryl-pyrimidines and their use in treatment of proliferative disorders
12/19/2007CN100355748C Aromatic hydrazide kind compound and its use in preparation of immune inhibitor
12/19/2007CN100355744C Separation and extraction of flavone natural product active component for treating prostating disorders and medicinal preparation preparing and use thereof
12/19/2007CN100355738C 1,2,4-triazole derivative, method for preparing the same, and pharmaceutical composition containing the same
12/19/2007CN100355735C Method for preparing arylalkyne
12/19/2007CN100355731C Pyridinum derivatives for management of aging-related and diabetic vascular complications, process for their prepn. and therepeutic uses thereof
12/19/2007CN100355729C Pleuromutilin
12/19/2007CN100355728C Inhibitors of dipeptidyl peptidase IV
12/19/2007CN100355714C Arylpiperazines having 5-hydroxyl-typtamine activity
12/19/2007CN100355457C Dispersible pharmaceutical compositions
12/19/2007CN100355455C Non-polymeric lipophilic pharmaceutical implant compositions for intraocular use
12/19/2007CN100355446C Synergistic medicinal composition
12/19/2007CN100355442C Medicinal composition for treating diabets, and its prepn. method
12/19/2007CN100355434C Medicine for preventing and treating cardiovascular and cerebrovascular diseases
12/19/2007CN100355432C Chinese and western compounded drug for treating alveolysis and its preparing method
12/19/2007CN100355426C Disodium adenosine triphosphate solid composition for injection and its preparing method
12/19/2007CN100355425C Stable granulates containing S-adenosylmethionine and process for the preparation thereof
12/19/2007CN100355424C Extractive of 'Zong'wood for treating diabetes, and application of saponin of 'Zong' wood for treating diabetes
12/19/2007CN100355423C Combination comprising a vasculostatic compound and an alkylating agent for the treatmemt of a tumor
12/19/2007CN100355422C Pharmaceutical composition containing platinum complex as active substance and method of manufacturing thereof
12/19/2007CN100355421C Use of docosahexanoic acid as active substance for the treatment of lipodystrophy
12/19/2007CN100355420C Leucine-enriched nutritional compositions
12/19/2007CN100355419C Therapeutic agent for overactive bladder
12/19/2007CN100355418C Magnetic nano-balls carried with cisplatin and its prepn. method
12/19/2007CN100355415C Frozen dry powder injection of astrogalus root and its preparing method
12/19/2007CA2602273A1 Composition and method for weight loss
12/18/2007US7310552 Apparatus for indirectly stimulating the vagus nerve with an electrical field
12/18/2007US7309800 Biphenylcarboxylic amide derivatives as p38 kinase inhibitors
12/18/2007US7309799 Asymmetric reaction of a cyclopropane carboxylic acid, ester, or amide or lactone or lactam with a phthalimide: potassium phthalimide; products are enantiomerically enriched
12/18/2007US7309796 Process for the preparation of 1,2-diaminocyclohexane-platinum(II) complexes
12/18/2007US7309792 Dimeric small molecule potentiators of apoptosis
12/18/2007US7309790 Chemical compounds
12/18/2007US7309789 4-phenyl substituted tetrahydroisoquinolines and therapeutic use thereof
12/18/2007US7309788 a selective N-alkylation reaction by adding a base; hydrolysing and amidating; useful for treating cardiovascular diseases caused by binding angiotensin II to its receptors, through antagonistic activity against angiotensin II receptors
12/18/2007US7309786 Dna sequences, Rna sequences; binding to tumor necrosis factor
12/18/2007US7309782 Pure crystalline azithromycin monohydrate hemi-ethanol solvate; nuclear magnetic resonance spectrum analysis; bactericides; antiprotozoa agents; infections of mammals, birds and fish; drug resistance .
12/18/2007US7309760 Repeat sequences of the CA125 gene and their use for diagnostic and therapeutic interventions
12/18/2007US7309721 Aminoalkylphosphonates and related compounds as Edg receptor agonists
12/18/2007US7309720 2-ethoxy-3-phenylpropionic acid derivatives for the treatment of lipid disorders
12/18/2007US7309719 Stabilized pharmaceutical preparation of gamma-aminobutyric acid derivatives and process for preparing the same
12/18/2007US7309718 Leukotriene D4 and E4 antagonists; antiasthmatic, antiallergic and antiinflammatory agents; oral absorbability, sustained action; such as [3-[(E)-2-(6,7-difluoroquinolin-2-yl)ethenyl]-5H-dibenzo[a,d]cyclohepten-5-yl]oxyacetic acid
12/18/2007US7309717 Process and intermediates for the preparation of (1R,2S,5S)-6,6-dimethyl-3-azabicyclo[3,1,0]hexane-2-carboxylates or salts thereof
12/18/2007US7309716 Inhibitors of voltage-gated sodium channels; acute, chronic, neuropathic, or inflammatory pain such as femur cancer pain; non-malignant chronic bone pain; rheumatoid arthritis; osteoarthritis; spinal stenosis; neuropathic low back pain; neuropathic low back pain; myofascial pain syndrome; fibromyalgia
12/18/2007US7309715 sulfonamide-substituted N-heterocyclics including pyrroles, oxazoles, thiazoles, imidazoles and their fused analogs, e.g., 3-Chloro-N-(2-ethylsulfanylbenzothiazol-6-yl)-2-methylbenzenesulphonamide; 11 beta -hydroxysteroid dehydrogenase inhibitors
12/18/2007US7309714 Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
12/18/2007US7309713 Use of the non-opiate analgesic drug flupirtine for the treatment of overactive bladder and associated diseases including urge incontinence, urinary flow problems as a result of prostate hyperplasia and irritable bowel syndrome
12/18/2007US7309712 1H-pyrazoles useful in therapy
12/18/2007US7309710 Crystals
12/18/2007US7309709 And oxazole sulfonamides: 3-(2-{1-[(4-Chloro-benzenesulfonyl)-(2,5-difluoro-phenyl)-amino]-ethyl}-thiazol-5-yl)-propionic acid, 4-Chloro-N-(2,5-difluoro-phenyl)-N-[1-(4-methyl-5-{[3-(2-oxo-pyrrolidin-1-yl)-propylamino]-methyl}-thiazol-2-yl)-ethyl]-benzenesulfonamide; Alzheimer's disease
12/18/2007US7309708 Serine protease inhibition via N-(distubstituted aminomethylcarbonyl)-2-[N-(1-sulfonylamido-1-cyclopropanyl)amido]pyrrolidines
12/18/2007US7309707 Crystalline micronisate, process for the manufacture thereof and use thereof for the preparation of a medicament
12/18/2007US7309706 Method for the treatment of diseases requiring inhibition or a reduction in the activity of pH value-regulating bicarbonate transporter proteins
12/18/2007US7309705 7-carboxamido- or sulfonamido-substituted: 2-Phenyl-3-cyclopropyl-7-(4-pyridylcarboxamido)pyrazolo[1.5a]pyrimidine; anticarcinogenic, antiinflammatory, neurodegenerative agent; arthritis, Alzheimer's disease, cardiovascular diseases, viral diseases and fungal diseases; with other active compounds
12/18/2007US7309704 Piperidinyl- and pyrimidinyl-ureas: N-(1-acetyl-4-piperidinyl)-N-methyl-N'-(5-(3,5-difluorophenyl)-2-pyrimidinyl)urea; metabolic disorders, eating disorders, disorders associated with obesity: type II diabetes, insulin resistance, hyperlipidemia or hypertension.
12/18/2007US7309703 Substituted pyrazoles useful for treating autoimmune diseases mediated by cathepsin S
12/18/2007US7309702 4-(3-Phenyl-3-carbocycloylpropyl)-1-phenyl- or pyridylpiperazine derivatives: 1-(2-methoxyphenyl)-4-[3-(benzoyl)-3-(phenyl)propyl]piperazine oxalate; serotonin receptor antagonists; Alzheimer's disease
12/18/2007US7309701 inhibitors of glycogen synthase kinase-3 beta; treatment of diabetes or neurodegenerative diseases such as Alzheimer's disease; 6-(2-butylamino-pyrimidin-4-yl)-3-oxo-2,3-dihydro-pyridazine-4-carboxylic acid (3-pyridin-3-yl-propyl)-amide, as example
12/18/2007US7309700 Crystalline dihydrate is more resistant to heat and humidity than the trihydrate; storage stability
12/18/2007US7309698 Compositions for delivering bisphosphonates
12/18/2007US7309697 Cyclic maltosylmatose
12/18/2007US7309696 Compositions and methods for targeting cancer cells
12/18/2007US7309694 Gene therapy; cytokine complex; anticancer agent
12/18/2007US7309693 Comprises antagonistic mutein of MCP-1 (monocyte chemoattractant protein-1: macrophage chemotactic factor)
12/18/2007US7309692 Inhibition of Grb2 and Crk1 gene products that interact with the bcr-abl product and participate in the transformation of Chronic myeloid leukemia
12/18/2007US7309691 Combined pharmaceutical preparation containing LHRH-analogous substances and anti estrogens for treating gynaecological disorders
12/18/2007US7309591 Method for the production of resveratrol in cell cultures
12/18/2007US7309508 Non-lauric, non-trans, non-temper fat compositions
12/18/2007US7309504 Therapeutic agent or preventor of hepatitis, TNF- alpha inhibitor, health supplementary food
12/18/2007US7309502 Pharmaceutical compositions for treating and saving and the method for the preparation thereof
12/18/2007US7309497 Injectable pharmaceutical composition for systematic administration of pharmacologically active ingredients
12/18/2007US7309487 Administering antibody that specifically binds to a matrix metalloproteinase membrane-associated 1 (MT1-MMP) protein for therapy of age-related macular degeneration
12/18/2007US7309483 Reducing pathological neovascularization in a human by administering to the human an agent capable of interfering with Ang2-mediated biological effects
12/18/2007CA2602189A1 Fat .beta.-oxidation enhancing and carbohydrate absorption inhibition
12/18/2007CA2489763C Pharmaceutical salts of reboxetine
12/18/2007CA2461070C Photochemotherapeutic method using precursors of protoporphyrin ix
12/18/2007CA2436799C Combinations of drugs (e.g., chlorpromazine and pentamidine) for the treatment of neoplastic disorders
12/18/2007CA2418479C Prodrugs of betulinic acid derivatives for the treatment of cancer
12/18/2007CA2416754C Cardiac arrest fluid
12/18/2007CA2378436C Method for producing antibiotic composites
12/18/2007CA2378087C New process for the preparation of n-(1,1-dimethylethyl)-4-[[5'-ethoxy-4-cis-[2-(4-morfolino)ethoxy]-2'-oxospiro[cyclohexan-1,3'-[h]indol]-1'(2'h)-yl]-sulfonyl]-3-methoxybenzamideand its salts
12/18/2007CA2325497C Dietary supplement for preventing or reducing shedding of hair
12/18/2007CA2299471C Combination of tyrosine kinase inhibitor and chemical castration to treat prostate cancer
1 ... 3457 3458 3459 3460 3461 3462 3463 3464 3465 3466 3467 3468 3469 3470 3471 3472 3473 3474 3475 3476 3477 ... 7860